Back to News
Market Impact: 0.15
Biotech Stocks At 52-Week Highs - KOD, MASS, OBIO, CDNA, PMVP
Source: Nasdaq
Healthcare & BiotechMarket Technicals & Flows
Biotech stocks highlighted by RTTNews reached 52-week highs on October 1, 2026, supported by catalysts including promising clinical-trial results and revised financial guidance. The report signals positive company-specific momentum in biotech, but provides no individual names, price moves, or financial magnitudes to assess broader sector impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- The next weak link in Europe’s bond market? UBS has a new short position
- Stocks remain under the thrall of higher yields and higher oil. Here's what's ahead
- Your health insurance premiums may take a big jump in 2027 — here's why
- Nasdaq Index: Record High as Weak Payrolls Cut Rate-Hike Bets and Yields Fall
- Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals
- Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s